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Abstract. Members of the epidermal growth factor 
(EGF) receptor family are known to be specifically in- 
volved in mammary carcinogenesis. As a nuclear target 
of activated receptors, we examined c-Jun in mammary 
epithelial cells. For this, we used a c-JunER fusion pro- 
tein which was tightly controlled by estrogen. Activa- 
tion of the JunER by hormone resulted in the transcrip- 
tional regulation of a variety of AP-1 target genes. 
Hormone-activated JunER induced the loss of epithe- 
lial polarity, a disruption of intercellular junctions and 
normal barrier function and the formation of irregular 
multilayers. These changes were completely reversible 
upon hormone withdrawal. Loss of epithelial polarity 
involved redistribution of both apical and basolateral 
proteins to the entire plasma membrane. The redistri- 
bution of E-cadherin and [3-catenin was accompanied 
by a destabilization of complexes formed between 
these two proteins, leading to an enrichment of 13-cate- 
nin in the detergent-soluble fraction. Uninduced cells 
were able to form three-dimensional tubular structures 
in collagen I gels which were disrupted upon JunER ac- 
tivation, leading to irregular cell aggregates. The 
JunER-induced disruption of tubular structures was de- 
pendent on active signaling by growth factors. More- 
over, the effects of JunER could be mimicked in nor- 
mal cells by the addition of acidic fibroblast growth 
factor (aFGF). These data suggest that a possible func- 
tion of c-Jun in epithelial cells is to modulate epithelial 
polarity and regulate tissue organization, processes 
which may be equally important for both normal breast 
development and as initiating steps in carcinogenesis. 
M 
AMMARY epithelial cells are  able to extensively 
modulate their phenotype when the mammary 
gland  changes  its  size  and  functional  activity 
during pregnancy, lactation, and weaning. These pheno- 
typical changes are regulated by numerous hormones and 
growth  factors  as  well  as  by interactions between  cells 
(Gabelman and Emerman, 1992; Oka et al., 1991; Streuli 
et al., 1991). Most of them involve alterations in epithelial 
polarity. 
Polarized epithelial cells are structurally and function- 
ally divided into several domains that contain distinct sets 
of proteins and lipids (Edidin, 1993; Simons et al., 1992). 
The apical domain faces the lumen of the mammary gland 
and is the site of milk protein secretion during lactation. 
The lateral domain is responsible for the close interaction 
between neighboring cells  via  different junctional com- 
plexes  such  as  tight junctions,  adherens  junctions,  gap 
junctions,  and  desmosomes  (Woods  and  Bryant,  1993). 
These complexes contain specific and/or common proteins 
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which  are  responsible  for the  intercellular  connections. 
Examples are ZO-1, a protein associated with tight junc- 
tions (Balda et al.,  1993),  and E-cadherin/uvomorulin, a 
transmembrane homophilic adhesion molecule that binds 
catenins and interacts with the cytoskeleton through pro- 
teins such as fodrin to form the adherens junctional com- 
plex (for review see Birchmeier and Behrens, 1994; Flem- 
ing et al., 1993). And finally, the basal membrane contacts 
the surrounding mesenchyme. The apical domain is sepa- 
rated from the basolateral part of the cell by a circumfer- 
ential ring of tight junctions, which is also responsible for 
the sealing of the intercellular space (Mandel et al., 1993). 
Thus, monolayers of epithelial cells form an effective bar- 
rier between the luminal and the interstitial compartments 
of the mammary gland. 
During  breast  cancer  development, the  phenotype of 
mammary epithelial ceils including cellular interactions, 
state of polarity, and response to proliferation and differ- 
entiation control is altered, eventually resulting in highly 
tumorigenic and invasive cell types (Birchmeier and Beh- 
rens, 1994; Fish and Molitoris, 1994). Several protein fami- 
lies,  acting at different stages in signal transduction cas- 
cades induced by extracellular signals, have been implicated 
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factor TGFa in transgenic mice leads to altered mammary 
gland development and neoplasia  (Matsui  et  al.,  1990). 
Amplification and/or mutational activation of receptor ty- 
rosine  kinases  including Neu/c-ErbB-2  (Dougall  et  al., 
1994) and EGF receptor (Jardines et al., 1993) is found in 
about one third of human breast tumors and is correlated 
with poor prognosis. Moreover, members of the FGF re- 
ceptor (FGFR)  1 family are amplified in another set of hu- 
man breast carcinomas (Adnane et al., 1991), stressing the 
important role of receptor tyrosine kinases in malignan- 
cies of the mammary gland. 
Ligand-activated growth factor receptors transmit their 
signals to the nucleus by activating components of various 
intracellular  signaling  pathways,  eventually  leading  to 
changes in  gene expression  (for review see Kazlauskas, 
1994). Blockage of growth factor-induced signal transduc- 
tion causes a  growth arrest  in mammary epithelial cells 
(Stampfer et al., 1993) and overexpression of components 
of the  Ras  pathway severely affects differentiation and 
proliferation of these cells in vivo and in vitro (Cha et al., 
1994; Daly et al., 1994; Jehn et al., 1992; Morrison and Le- 
der, 1994). 
Several  members  of the  AP-1  family of transcription 
factors, including c-Fos and c-Jun, are nuclear targets of 
these signal transduction pathways (Deng and Karin, 1993; 
Derijard et al., 1994; Engelberg et al., 1994). AP-1 proteins 
form homo- and/or heterodimeric complexes and bind to a 
common sequence element known as the TPA-responsive 
element (TRE; for review see Woodgett, 1990). c-Fos in- 
duces severe changes of epithelial polarity in mammary 
epithelial cells (Jehn et al., 1992; Reichmann et al., 1992). 
However, c-Jun and c-Fos are subject to different regula- 
tory mechanisms (Minden et al., 1994; Rapp et al., 1994). 
c-Jun is the nuclear target of ErbB-2-induced (Ben-Levy 
et al., 1994) and other Ras/MAP kinase-dependent signals 
(Derijard et al., 1994) and its activity is required for onco- 
genic transformation (Brown et al.,  1993).  We therefore 
were interested to study the potential role of this oncopro- 
tein in the modulation of the normal, polarized phenotype 
of epithelial cells and in breast carcinogenesis. 
In this paper, we show that activation of an estrogen- 
dependent  c-JunER  fusion protein  in  mouse  mammary 
epithelial cells causes a reversible loss of epithelial polar- 
ity. The tight contacts between cells are loosened, leading 
to irregular multilayers on permeable supports and forma- 
tion of solid cords instead of hollow ducts in collagen gels. 
In  addition,  the  E-cadherin/[3-catenin  complex  is  dis- 
rupted,  and its components are  redistributed.  This does 
not involve tyrosine phosphorylation of [3-catenin,  which 
has been implicated in the loss of cell adhesiveness after 
v-src transformation (Behrens et al.,  1993; Hamaguchi et 
al.,  1993).  Supporting  the  idea  that  activated  c-JunER 
mimics the physiological effects of endogenous c-Jun, the 
phenotype  is  thoroughly dependent  on  growth  factors. 
Moreover, we can induce a similar phenotype in collagen 
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IV; E2, [3-estradiol;  ER(HBD), estrogen receptor (hormone-binding do- 
main); FGFR, fibroblast growth factor receptor; PAI-1, plasminogen acti- 
vator inhibitor-I; TER, transepithelial electrical  resistance; TRE, TPA- 
responsive element; UPA, urokinase-type plasminogen activator. 
gels  by  the  addition  of  acidic  fibroblast  growth  factor 
(aFGF). 
Materials and Methods 
Cells and Cell Culture 
EpH4 cells (H4) were generated by infecting spontaneously immortalized 
Epl  cells  (Reichmann  et  al.,  1992)  with  the  empty  retroviral  vector 
pHMW and subcloning the cells in the presence of 115 Ulml hygromycin 
B  (Calbiochem Corp., La Jolla, CA). Clones obtained built up polarized 
monolayers when grown on permeable filters and exhibit high transepi- 
thelial electrical resistance (TER), as well as polarized expression of api- 
cal and basal epithelial marker proteins (L6pez-Barahona et al., 1995). 
They form three-dimensional, tubular structures when cultured in col- 
lagen I gels and other extracellular matrices. Cells were routinely cultured 
in DMEM supplemented with 5%  FCS  (Boehringer Ingelheim) and 10 
mM Hepes, pH 7.3, as described (Reichmann et  al., 1992).  13-Estradiol 
(E2; Sigma Chem. Co., St. Louis, MO) was used at a concentration of 10  -6 
M. Ethanol was used as a solvent control (-E2). For culture on perme- 
able filters, cells were counted in a CASY 1 (Sch~irfe System), and 2.5-3 × 
105 cells seeded on cell culture inserts (Falcon 3090).  MDCK ts v-src cells 
were cultured as described (Behrens et al., 1993). 
Culture in Collagen I Gels 
Cells were seeded in collagen I (Sigma Chem. Co.) gels as described (Reich- 
mann et al., 1992) at 2 x  104 cells/ml with the following modifications. Af- 
ter the collagen gels had polymerized, they were overlaid with serum-free 
mammary epithelial cell basal medium (PromoCell) supplemented with 
0.4% bovine pituitary extract (BPE; PromoCell), 0.04 IU/ml insulin, 10  -6 
M isoproterenol, 25 ng/ml hydrocortisone and 2.5 ng/ml TGFcc. 
Retroviral Infection 
Retroviral vectors pMV-7 and pMV-ER(HBD) and pMV-c-jun have been 
described previously (Bergers et al., 1994; Kirschmeier et al., 1988). pMV- 
junER was constructed by fusing a  990-bp PstI-BspHI c-jun fragment 
from pMV-c-jun together with an oligonucleotide, restoring the complete 
cDNA of c-jun, in-frame into the PstI-BamHI sites upstream of the hor- 
mone-binding domain in pMV-ER(HBD). GP+E packaging cells (Mar- 
kowitz et al., 1988) were transfected with the respective constructs as de- 
scribed  (Reichmann et  al.,  1992)  and selected in 0.8 mg/ml G418.  For 
retroviral infection, epithelial H4 were cocultured for 2 d with resistant vi- 
rus-producing GP+E cells pretreated with 10 p~g/ml mitomycin C for 5 h. 
Epithelial  cell clones were selected in  1 mg/ml G418, isolated, and ex- 
panded as described (Reichmann et al., 1992). 
Chloramphenicol Acetyltransferase  Assay 
Clones of the GP+E packaging line expressing the respective retroviral 
constructs were transfected by calcium phosphate coprecipitation with re- 
porter plasmids. These were vectors containing the CAT gene fused to 
parts of the human collagenase promoter either lacking the TRE (-63 
Col-CAT) or containing one  TRE  (-73  Col-CAT) or a  pentamerized 
binding site in front of the minimal thymidine kinase promoter (p(-73/ 
-65)5  tk-CAT). Generation of the reporter  plasmids is described else- 
where (Yang-Yen et al., 1990). The cells were washed and scraped off the 
culture dish in PBS on ice, pelleted, resuspended in PBS, and spun in an 
Eppendorf centrifuge at top speed for 20 s. After resuspension in 100 v.l 
0.25 M Tris/HC1, pH 7.5, they were disrupted by three freeze/thaw cycles 
and cell debris was pelleted (5 rain, 14,000  rpm). The protein concentra- 
tion of the supernatant was determined and extracts containing identical 
amounts of protein were subjected to CAT assay. 
RNA Preparation and Northern Blot Analysis 
Total RNA was prepared essentially as described (Puissant and Houde- 
bine, 1990).  Briefly, after guanidinium thiocyanate extraction and isopro- 
panol precipitation the pellets were resuspended in 1 ml 4 M LiC1 to solu- 
bilize copurified polysaccbarides. RNA was pelleted, resuspended in 10 
mM Tris/HC1, pH 7.5, 1 mM EDTA, 0.5% SDS and precipitated with eth- 
anol. 10 ~tg of RNA was separated in 1.5% agarose and transferred onto 
Gene Screen  TM membranes (New England Nuclear, Boston, MA). Single 
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golabeling Kit (Pharmacia LKB Biotechnology, Piscataway, N J) and hy- 
bridized at 65°C in 7% SDS, 0.5 M  NaPhosphate, pH 7.0,  1 mM EDTA. 
Membranes were washed in 1% SDS, 40 mM NaPhosphate at 65°(? and 
autoradiographed.  Probes  used were fra-I  (Bergers et  al.,  1995),  UPA 
(urokinase-type plasminogen activator), PAl-1 (plasminogen activator in- 
hibitor 1) (Reichmann et al., 1992), and mousejunB andjunD. 
Immunoprecipitation and Subcellular Fractionation 
For immunoprecipitation, cells were grown on filter culture inserts (75 
mm, Costar Corp., Cambridge, MA), scraped off the filters in 1% Triton 
X-100 in L-CAM assay buffer, supplemented with protease inhibitors and 
0.2 mM sodium orthovanadate as described by Behrens et al. (1993), ex- 
tracted  1 h  on ice and aliquots containing identical amounts of protein 
subjected to immunoprecipitation. Precipitates were resuspended in sam- 
ple buffer and analyzed by immunoblotting as described below. 
Subcellular fractionation of cells grown on filters (75 mm, Costar) was 
performed essentially as described by Navarro et al. (1993). Fractions sol- 
uble and insoluble in 2.5%  NP-40 were analyzed by immunoblotting as 
described below. 
Whole Cell Protein Extracts and Immunoblotting 
Cells were scraped off the culture dish in Ix  Laemmli SDS gel sample 
buffer, boiled for 5 min and proteins were separated in 6-15% SDS-poly- 
acrylamide gradient gels. For immunoblots the proteins were transferred 
onto Nitrocellulose BA 85 (Schleicher & Schuell, Keene, NH) which was 
subsequently blocked with 3% BSA (Sigma) in PBS, 1 mM EDTA and 
0.05% Tween 20 (block buffer). The antibody reaction was performed in 
block  buffer containing 0.02%  NaAzide  for  at  least  2  h.  Filters  were 
washed three times for 10 min in 50 mM Tris/HCl, pH 8.0, 0.1 M NaCI and 
0.1%  Tween 20  (wash buffer), incubated with horseradish peroxidase- 
conjugated secondary antibody (1:105) in 5% milk powder in PBS (freshly 
prepared) for 30 rain, washed three times and subjected to immunodetec- 
tion using ECL Western blotting reagents (Amersham Corp.). All steps 
were performed at room temperature. Stripping of blots was performed 
according to the manufacturer's specifications. 
Densitometry 
To quantify data from Western blots and combined immunoprecipitation 
Western analysis, films were scanned with a Personal Densitometer (Mo- 
lecular Dynamics, Sunnyvale, CA). In each case, data from two indepen- 
dent experiments were scanned twice and the values obtained averaged. 
Standard deviations were <10% in all cases. 
Immunofluorescence 
Cells grown on filters were fixed and permeabilized either with acetone/ 
methanol 1:1 at -20°C for 3 min or with 3% paraformaldehyde (PFA) in 
0.2 M Hepes, pH 7.3, 1 mM CaC[2, 1 mM MgC12, followed by 0.5% Triton 
X-100 in the same buffer. The filters were cut into pieces for staining with 
several antibodies, blocked with 0.2%  gelatin in PBS for 30 min, incu- 
bated  with  primary antibodies in PBS/gelatin  for 60 rain, washed four 
times for 10 min and incubated with secondary antibodies for 30 min. Af- 
ter three washes for 5  min, filter pieces were mounted with Mowiol in 
PBS, covered with coverslips and subjected to confocal microscopy. 
Microscopy 
Cells grown either on permeable filters or in collagen I gels were prefixed 
10 rain in 3% PFA in 0.2 M  Hepes, pH 7.3,  at room temperature. Cells 
were further fixed in 8% PFA, 0.2 M Hepes, pH 7.3, for 30-60 min on ice. 
For ultrastructural studies cells were postfixed with 1% osmium tetroxide 
in PBS, pH 7.2, for 1 h on ice, block stained with 1% aqueous uranyl ace- 
tate for 1 h, dehydrated in ethanol at room temperature and finally em- 
bedded in Epon.  Ultrathin sections (50-70 nm thick) were stained with 
uranyl acetate and lead citrate and viewed in a Philips CM10 transmission 
electron microscope at 60 kV. For scanning electron microscopy, samples 
were fixed and block stained as described above, dehydrated in isopro- 
panol, and critical point-dried from carbon dioxide. The specimens were 
sputter-coated with 6 nm gold-palladium and inspected in a Hitachi S-800 
scanning electron  microscope. For  immunocytochemistry samples were 
dehydrated in ethanol at progressively lower temperatures, embedded in 
Lowicryl HM20 and polymerized at  -35°C by UV light (Schwarz et al., 
1993). Ultrathin sections were mounted on coverslips (Schwarz, 1994). Af- 
ter blocking unspecific binding sites with 0.5% BSA and 0.2% gelatin in 
PBS, sections were incubated with rabbit anti-[~-catenin antibodies and 
subsequently with Cy3-1abeled goat anti-rabbit IgG. To visualize Cy-3 flu- 
orescence at an improved signal to noise ratio, a bandpass filter set for 
Cy  3  (Chroma High  Q  No.  F41-007, AF -Analysentechnik, Tiibingen, 
FRG) was used instead of a conventional TRITC filter. The labeled sec- 
tions were stained with 4',6-diamidino-2-phenylindole (DAPI) to visualize 
nuclei in immunofluorescence microscopy. 
For confocal microscopy cells were stained by immunofluorescence as 
mentioned above and visualized by use of a 600 confocal fluorescence mi- 
croscope fitted with a confocal imaging system (Bio-Rad, England). The 
distance between two scanning planes was 0.2 p~m. 
Transepithelial Electrical Resistance Measurements 
Cells were grown on filter culture inserts (Falcon 3090). The functional in- 
tegrity of tight junctions was assayed by measuring the TER of cell layers 
using the Millicell Electrical Resistance System (Millipore Corp., Bedford, 
MA) and the electrode system Endohm-24 (World Precision Instruments, 
New Haven, CT). TER values were calculated after subtraction of the 
very low background of blank inserts. 
Antibodies 
Rabbit antiserum to c-Jun was a gift from Dr. M. Nicklin (Royal Hallam- 
shire Hospital, Sheffield). Mouse monoclonal antibody to the hormone- 
binding domain of the human estrogen receptor (F3) has been described 
(All et al., 1993).  Mouse monoclonal antibody against the apical protein 
dipeptidyl peptidase IV (DPPIV) was kindly provided by Dr. M. Pierres 
(Centre d'Immunologie de Marseille-Luminy). Rat monoclonal antibody 
(mAb1622) to ZO-1, a tight junctional marker protein, was obtained from 
Chemicon Intl., Inc. (Temecula, CA). Rabbit  antiserum specific for the 
84-kD fragment of E-cadherin was kindly provided by  Dr.  R.  Kemler 
(Max-Planck-Institut fi~r Immunbiologie, Freiburg) and polyclonal anti- 
body to 13-catenin was a kind gift from Dr. J. Behrens (Max-Delbr0ck-Zen- 
trum ffir Motekulare Medizin, Berlin) and Dr. S. Schneider (Max-Planck- 
Institut  fiir  Entwicklungsbiologie,  Ttibingen).  Anti-phosphotyrosine 
mouse monoclonal clone 4G10 was purchased from UBI and affinity-puri- 
fied labeled secondary antibodies were obtained from Amersham. Cy-3-- 
labeled  antibodies  were  from  Jackson  ImmunoResearch  Labs  (West 
Grove, PA). 
Results 
Expression of a Functionally Active c-JunER Protein in 
Epithelial  Cells 
To analyze the potential effects of c-Jun in mammary epi- 
thelial cells, we constructed retroviral expression vectors 
containing a  fusion protein of c-Jun with the  hormone- 
binding domain of the human estrogen receptor (pMV-jun 
ER). Retroviral vectors expressing bona fide c-Jun (pMV- 
c-jun), the hormone-binding domain of the  estrogen re- 
ceptor [ER(HBD)]  alone  [pMV-ER(HBD)] or only the 
neomycin resistance gene as a selectable marker (pMV-7) 
were used as controls (Fig. 1 A; see Materials and Meth- 
ods). For production of viruses these vectors were trans- 
fected into the  fibroblastic packaging  line  GP+E  (Mar- 
kowitz et al., 1988). These cells were also used to test the 
estrogen-dependent transactivation function of the retro- 
virally transduced conditional c-JunER protein (also re- 
ferred to as JunER). For this, GP+E fibroblasts express- 
ing JunER or ER(HBD) were transiently transfected with 
reporter plasmids containing the CAT gene fused to parts 
of the human coUagenase promoter, containing no TRE, 
one TRE, or the pentamerized AP-l-binding site (Yang- 
Yen et al.,  1990). The cells were cultivated in the absence 
or  presence  of E2.  JunER-expressing  fibroblasts  trans- 
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very high CAT activity in the presence but not in the ab- 
sence  of hormone  (Fig.  1  B).  As  expected,  transfection 
with the construct lacking the TRE lead to only basal tran- 
scription levels even after E2 addition. Furthermore, only 
basal levels of CAT activity was detected in cells express- 
ing  the  ER(HBD)  with  all  the  reporter constructs  used 
(Fig. 1 B), confirming the protein's lack of transactivation 
potential. 
Next, mammary epithelial cells capable of full epithelial 
polarization  (H4 cells,  see Materials  and  Methods)  were 
infected  with  the  retroviruses  shown  in  Fig.  1 A.  G418- 
resistant clones (H4 pMV, H4 c-jun, H4 ER(HBD),  and 
H4 junER, respectively) were tested for RNA and protein 
expression by Northern analyses and immunoblots, mRNAs 
of the expected lengths (data not shown) and proteins of 
the expected sizes (Fig. 1 C) were detected in the infected 
cells. The JunER protein (Mr =  70-75) reacted with anti- 
bodies against c-Jun and against the hormone-binding do- 
main of the human ER (F3; Ali et al., 1993). As expected, 
c-Jun (Mr =  39; both endogenous and retroviral) failed to 
react with F3 antibody, whereas the  ER(HBD) polypep- 
tide (Mr =  33) was exclusively detected with F3 (Fig. 1 C). 
In addition, the ER-specific antibody also reacted with en- 
dogenous estrogen receptor (mER; Mr =  66; Parker et al., 
1993). 
Expression and localization of JunER in epithelial cells 
plus or minus estradiol was also checked by indirect immu- 
nofluorescence  (Fig.  1  D).  The  JunER  protein  was  dif- 
fusely expressed  throughout  the  cytoplasm  and  the  nu- 
cleus  in  the  absence  of  E2  but  showed  clear  nuclear 
accumulation in the presence of E2. Similar levels of nu- 
clear c-Jun were expressed in H4 c-jun clones, but in a hor- 
mone-independent  fashion  (data  not  shown).  Thus,  the 
retrovirally infected cells expressed the expected proteins 
in substantial amounts and in the appropriate subcellular 
compartments. 
Regulation of  AP-1 Target Genes by JunER in 
Epithelial  Cells 
Having shown in fibroblasts that c-JunER behaved like a 
Figure 1. Structure,  biological activity, and expression of retroviral vectors used. (A) Structures  of the retroviral vectors pMV-7, pMV- 
ER(HBD), pMV-c-jun, and pMV-junER. LTR, long terminal repeat. (B) Virus  producing  fibroblasts  expressing  the fusion protein 
JunER or ER(HBD) were transiently transfected with the reporter constructs  -73 Col-CAT (-73), p(-73/-65)5 tk-CAT [(-73/-65)5] 
and -63 Col-CAT (-63). The cells were grown in the presence (+) or absence (-) of E2 for 1 d. Cell extracts containing equal protein 
amounts were analyzed for CAT expression. (C) Epithelial  H4 cells were infected with the various retroviral constructs and clones were 
grown in the absence (-) and presence (+) of E2 for 2 d. Protein lysates of cells were analyzed by SDS-PAGE and immunoblots using 
antibodies  to c-Jun (ct-c-Jun)  and to ER(HBD) (a ER). (D) H4 junER cells were cultivated  without (-E2) or with (+E2) hormone, 
immunostained with ct-c-Jun and subjected to confocal microscopy (horizontal  section through the nuclei). 
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to determine in epithelial cells, if known AP-1 target genes 
were regulated by JunER in  a  hormone-dependent fash- 
ion. Such genes include other members of the AP-1 family 
(Bergers et al.,  1995;  Rozek and Pfeifer, 1993)  as well as 
proteases and their inhibitors (Hu et al., 1994; Knudsen et 
al., 1994; Lee et al., 1993; Reichmann et al., 1992). H4 cells 
expressing  JunER,  ER(HBD)  or  no  exogenous  protein 
were cultivated in the presence or absence of E2 for 2 h, as 
well as for 1, 2, or 4  d.  Total RNA prepared from these 
cells was then studied by Northern blot analysis. 
Two interesting  findings  were  obtained.  First,  mRNA 
expression  of  several  AP-l-regulated  genes,  including 
junB, fra-1 (Bergers et al., 1995), the protease UPA and its 
inhibitor PAI-1,  strongly decreased  with  time in  the  ab- 
sence  of an  active JunER  (Fig.  2,  left panel). This  sug- 
gested an effect of cell density and/or epithelial polariza- 
tion  on  the  expression  of these  genes.  In  contrast,  the 
expression of junD mRNA (Li et al.,  1992;  Ryder et al., 
1989) was comparatively high on day 4 (Fig. 2, left panel). 
Loss of expression of these genes with time in culture was 
clearly an intrinsic property of the parental cell line, since 
it also occurred in H4 and H4 ER(HBD) cells, regardless 
of the presence or absence of hormone (data not shown). 
More importantly, JunER  activated or repressed most 
of these  genes in  a  hormone-dependent  fashion.  Activa- 
tion of JunER caused a strong repression of junB as soon 
as 2 h  after hormone addition, which was not observed in 
control parental H4 cells (Fig. 2, right panel). This junB 
downregulation  was also visible after longer times of E2 
induction  (not  shown).  A  similar,  albeit  much  weaker, 
downregulation by JunER was seen continuously for junD 
from day 1. In contrast, a strong E2-dependent upregula- 
tion offra-1,  UPA, and PAI-1 mRNAs was seen at day 2 in 
the  JunER-expressing  cells  (Fig.  2,  right panel). At  this 
time  point,  expression  of these  genes  had  already  been 
abolished in the absence of an active JunER by the den- 
sity-dependent  mechanism  described  above  (Fig.  2,  left 
panel). Again, this effect was not observed in control cells 
(H4, Fig. 2; H4 ER(HBD), not shown). In summary, our 
results show that several genes known to be regulated by 
AP-1 proteins were indeed subject to regulation in the epi- 
thelial cells by activation of JunER. 
Activation of JunER in Polarized Epithelial  Cells 
Causes Loosening of Cell Contacts and Redistribution 
of  Apical and Basolateral Proteins 
Having demonstrated that the JunER protein was regulat- 
ing target gene expression in the epithelial cells in a  hor- 
mone-dependent fashion, we next wanted to analyze pos- 
sible effects of the activated JunER protein on the state of 
epithelial  polarization.  Analysis  of  another  conditional 
AP-1 protein, c-FosER, had already shown that its activa- 
tion by E2  disrupted  epithelial polarity and even caused 
epithelial-mesenchymal transition (Reichmann et al., 1992). 
Therefore, we sought to determine whether or not the ef- 
fects of the c-Fos and c-Jun fusion proteins were distinct. 
H4 junER and control parental H4 cells were grown on 
permeable filter supports for 4 d in the absence and pres- 
ence  of E2.  Morphological  analysis  by  scanning  (SEM) 
and transmission (TEM) electron microscopy showed that 
Figure 2. Regulation of AP-1  target genes by activated JunER. 
H4 junER cells and control H4 cells were grown with or without 
E2 for various time periods (2 h; 1, 2, and 4 d). For the 2-h incu- 
bation period, the cells were kept in culture for 1 d before induc- 
tion and then treated with hormone (+) or left untreated (-) for 
2 h. Total RNA was analyzed on Northern blots. The left panel 
shows the density  dependent decrease in mRNA levels (RNAs 
from H4 junER cells grown in the absence orE2 for 1, 2, and 4 d). 
In  the  right  panel,  JunER-induced  down-  or  upregulation  of 
genes is shown at the earliest time point, at which these effects 
were clearly visible. For visualization ofjunB- mRNA downregu- 
lation,  H4 junER ceils were treated (+) or not treated with E2 
(-) for 2 h. junD mRNA downregulation  was evident after 1 d 
and upregulation of fra-1, UPA and PAI-I mRNAs was visible 
after 2 d. Note that RNA levels do not change in H4 control cells 
upon E2 treatment for identical  time periods.  18 S rRNA con- 
firms equal loading (~E2 for 2 d is shown in right panel). 
uninduced H4 junER (Fig. 3,  -E2), as well as control H4 
cells in  the  presence or absence of E2  (data not  shown) 
formed monolayers of tightly connected  cells.  Microvilli 
were expressed only at the apical surface. In contrast, the 
E2-activated  JunER  induced  a  dissociation  of tight  cell 
contacts, cell rounding, and growth in multilayers (Fig. 3, 
+E2). The addition of hormone also caused a distribution 
of microvilli expression over the entire cell surface. Exam- 
ination by TEM at higher magnification revealed that tight 
junctions appeared to be reduced in number and morpho- 
logically abnormal after JunER  activation.  Extensive in- 
terdigitations  of lateral  plasma  membranes  as  observed 
between neighboring,  uninduced  control cells were com- 
pletely absent  in  the  E2-treated  H4 junER  cells leaving 
large gaps and clefts between the loosely contacting cells. 
To  investigate  if these  morphological  alterations  were 
Fialka et al. c-JunER-induced  Reversible Loss of Polarity  1119 The Journal of Cell Biology, Volume 132, 1996  1120 Figure 4. The polarized expression of basolateral and apical proteins is disrupted by JunER activation. (A) H4 junER were grown on fil- 
ters without (-E2) or with E2 (+E2) as described in Fig. 3, fixed and stained by immunofluorescence for DPPIV, E-cadherin, ZO-1, 
and [3-catenin. The staining was visualized  as vertical sections employing a confocal microscope. To improve the resolution of fluores- 
cence signals, we extended the Z-axis to double the actual height of the cells (compare to B). Positions of filter membranes are indicated 
by white lines. (B) Ultrathin Lowicryl HM20 sections of such filters were stained for 13-catenin (yellow) and nuclei visualized with DAPI 
(blue). Due to a different nuclear geometry, the nuclei in B appear bigger in the presence of estradiol than in its absence. Bars: 10 p.m. 
accompanied by a  loss of epithelial  polarity,  the distribu- 
tion  of apical  and basolateral/junctional  proteins  was in- 
vestigated. Cells grown on porous supports were analyzed 
for the localization of such proteins  using indirect immu- 
nofluorescence  and  confocal microscopy (Fig.  4  A). The 
apical  marker  DPPIV  (Casanova  et  al.,  1991)  was  re- 
stricted to the apical membrane domain in JunER cells in 
the absence of E2, while it became redistributed  over the 
entire membrane after E2 treatment (Fig. 4 A). Staining of 
the  junctional  proteins  E-cadherin  (Gumbiner  and  Mc- 
Crea, 1993; Kemler, 1993), [3-catenin (Gumbiner and Mc- 
Crea, 1993; Kemler, 1993), and ZO-1 (Madara et al., 1993) 
demonstrated  that all of these proteins were restricted  to 
the lateral cell membrane in the absence of E2. ZO-1 was 
specifically concentrated at the sites of tight junctions (Fig. 
4 A). Upon JunER activation, all the basolateral proteins 
were completely redistributed.  13-Catenin and ZO-1 were 
barely detectable by immunofluorescence in the E2-treated 
cells (Fig. 4 A). Again, the JunER-induced formation of ir- 
regular  multilayers  and  rounding  up  of cells  was  clearly 
visible (see also Fig. 3). 
For 13-catenin,  the results  of confocal microscopy were 
confirmed by fluorescence microscopy (Fig. 4 B) or immu- 
noelectron microscopy (data not shown) of ultrathin Low- 
Figure 3. Activation of JunER in epithelial cells induces loosening of cell contacts and multilayer formation. 2.5 ×  105 H4 junER cells 
were seeded on permeable filter membranes and grown either with (+E2) or without (-E2) hormone for 4 d. The cells were then fixed 
and prepared for TEM and SEM. Uninduced cells form monolayers of polarized and tightly connected cells with apical microvilli  and 
massive interdigitations (small arrowheads,  left bottom panel). In the presence of E2, the cells form irregular multilayers with enlarged 
intercellular spaces (arrows and asterisks in right panels). Still, we can detect occasional but atypical structures possibly resembling dis- 
rupted tight junctions (compare large arrowheads in bottom panels). Bars: (upper and middle panels) 10 ~m; (bottom panels) 1 ~m. 
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I~-catenin  in the JunER cells without E2 treatment. After 
E2 addition, p-catenin was redistributed to the whole cell 
surface of the loosely connected irregular ceils. No alter- 
ations  of the polarized expression of all  tested proteins 
were observed in control parental and H4 ER(HBD) cells 
irrespective of hormone (not shown).  We conclude that 
E2-activated JunER effectively  induces loss of epithelial po- 
larity in mammary epithelial cells. 
JunER-induced Loss of  Epithelial Polarity Disrupts 
Tubular Morphogenesis in Collagen I Gels 
To determine whether the c-Jun effects observed in epi- 
thelial  cells were physiologically relevant, we  sought  to 
elucidate if the loss of cell adhesion and epithelial polarity 
induced by activated JunER would have an effect on the 
formation of glandlike structures that can be obtained in 
collagen I  gels (see Materials and Methods). Within 2-3 
wk in the absence of E2, H4 junER cells formed three- 
dimensional, branching tubular structures with clearly visi- 
ble lumina (Fig. 5 A, day 0, arrows) that closely resembled 
the ducts of the mammary gland in vivo. 24 h after the ad- 
dition of E2 (day 1), these lumina were disrupted (arrows), 
leading to cordlike structures. The tight contacts between 
the cells appeared to be loosened. Even after 4 d of hor- 
mone treatment we did not observe cellular invasion into 
the  extracellular matrix  (Fig.  5 A,  day 4).  TEM  micro- 
graphs  from  ultrathin  sections  through  such  branched 
structures showed that H4 junER cells without E2 formed 
tubules of tightly connected cells. In contrast, the struc- 
tures after hormone addition represented irregular cords 
of loosely connected cells without any lumen (Fig. 5 B). 
Cells growing on top of the gels exhibited exactly the same 
phenotypes as ceils grown on filter supports (see Fig. 3). 
No alterations of tubular morphogenesis could be induced 
by E2 in  control H4  and H4 ER(HBD)  cells  (data not 
shown). 
Staining of such ultrathin sections with p-catenin anti- 
body revealed that  the  adherens junctional protein was 
strictly basolaterally expressed in the glandlike tubules un- 
der normal conditions (Fig. 6). By immunogold electron 
microscopy of corresponding serial sections  (Schwarz et 
al., manuscript in preparation), the seemingly apical fluo- 
rescence of occasional cells (Fig. 6) could be shown to lo- 
calize to lateral contacts between two neighboring cells, 
the apical to basal axes of which were differing from the 
sectional plane. In contrast, hormonal activation of JunER 
caused p-catenin redistribution in the cells forming disor- 
ganized cords (Fig. 6). We conclude that activated c-JunER 
also inhibits tubular morphogenesis of mammary epithe- 
lial cells. 
HormonaUy Activated JunER Mimics the Activation of 
Endogenous c-Jun by Cellular Signaling Pathways 
c-Jun transcriptional activity is regulated by protein phos- 
phorylation as  a  consequence of growth factor receptor 
signaling  (Minden  et  al.,  1994;  Nikolakaki  et  al.,  1993; 
Smeal et al., 1994). We therefore examined whether c-JunER 
activity was still dependent on growth factor-induced sig- 
nals. H4 junER cells were precultured in serum-free col- 
lagen I  gels in the presence of growth factors (BPE and 
TGFa) required for cell growth and formation of branch- 
ing  tubules  (Fig.  7  A).  After  branching  tubules  had 
formed, the growth factors were withdrawn for 1 d, and 
then E2 was added in the absence of growth factors. Even 
after 4 d of E2 treatment, the formed tubules maintained 
their lumina and did not collapse (Fig. 7 A). Withdrawal of 
factors had no visible adverse effects on cell viability, but 
solely inhibited further growth, as seen in control cultures 
lacking both growth factors and estrogen (Fig. 7 A). 
Having shown that JunER, similar to bona fide c-Jun, 
requires upstream cellular signals to affect epithelial po- 
larity  in  collagen  I  gels,  we  wanted  to  study  whether 
growth factor receptors that are known to signal via c-Jun 
could act on epithelial polarity in a similar fashion as hor- 
mone-activated JunER.  Using  the  same  conditions  that 
were  employed for JunER  activation,  parental  H4 cells 
were grown in collagen I  gels (Fig. 7 B, 0 h) and subse- 
quently  treated  with  various  growth  factors.  Strikingly, 
aFGF (5 ng/ml) in the presence of heparin (Spivak-Kroiz- 
man et al.,  1994) was able to induce a phenotype almost 
identical  to  that  seen with  activated JunER  (Fig.  7  B). 
Within 48 h of growth factor treatment preformed lumina 
(long arrows) collapsed. Heparin alone (control) did not 
induce any phenotypical changes (short  arrows). 
We conclude from these data that the presence of exter- 
nal upstream signals is a prerequisite for the E2-induced 
activation of the chimeric JunER protein. Moreover, aFGF 
affects the mammary epithelial phenotype similar to acti- 
vated JunER, presumably by activating endogenous c-Jun. 
Loss of Epithelial Polarity and Junctional 
Integrity Caused by JunER Is Fully Reversible after 
Hormone Withdrawal 
In earlier work (Reichmann et al., 1992), we demonstrated 
that  the  time span  during  which  a  conditional c-FosER 
was  activated was  of crucial  importance  to its  effect in 
mammary  epithelial  cells:  loss  of epithelial  polarity in- 
duced by a short-term activation for 30-60 min was fully 
reversible, while long-term activation of c-FosER resulted 
in an irreversible epithelial-mesenchymal transition (Reich- 
mann et al., 1992).  Since c-Fos exhibits its transactivation 
activity in heterodimeric complexes with c-Jun, we were 
interested  to  learn  whether  epithelial  cells  expressing 
JunER would behave similarly or differently to Ep-fosER 
cells regarding reversibility of the induced alterations. 
A  rapid and quantitative method to assess the state of 
epithelial polarity and the integrity of epithelial cell mono- 
layers seeded on porous supports is to measure TER (see 
Materials and Methods; Cereijido et al.,  1993; Mandel et 
al.,  1993).  As an indication for the progressive sealing of 
tight junctions, the TER of H4 junER cells continued to 
Figure 5. Activated JunER induces disruption of tubular morphogenesis in collagen I gels. (A) Cells were seeded in collagen I gels at a 
density of 2 x  104 cetls/ml and kept in culture for three weeks until branching, tubular structures had developed (day 0). The gels were 
further cultivated with (+E2) or without hormone (-E2) for 4 d and the same structures photographed 1 d (day 1) and 4 d (day 4) after 
The Journal of Cell Biology, Volume 132, 1996  1122 hormone addition. Note the E2-induced disruption of lumina (arrows) in glandlike multicellular structures and the inability of the cells 
to invade the gel, even after 4 d of JunER activation. (B) On day 4 these gels were processed for EM. Histological staining of ultrathin 
Epon sections confirms the loss of lumen in hormone-treated cells. L, lumen; G, gel. Cells growing on top of the gels show the same phe- 
notypes as on filters. Bars: 10 I-tm. 
Fialka et al. c-JunER-induced Reversible Loss of  Polarity  1123 Figure 6. 13-Catenin labeling of sections through collagen gel-grown cell structures.  H4 junER structures grown in collagen I gels were 
treated with (+ E2) or without (-E2) hormone for 4 d, fixed, and embedded in Lowicryl HM20. Ultrathin sections were immunostained 
with a 13-catenin-specific antibody and counterstained with DAPI (see legend to Fig. 4). 13-Catenin is restricted to the basolateral sites of 
the cell monolayer enclosing a lumen (-E2) and completely redistributed  over the whole membrane in cells arranged in irregular cords 
(+E2). Bars: 10 ixm. 
increase in  the  absence of E2  (Fig. 8 A, open symbols), 
similar to that of control H4 ER(HBD) and H4 parental 
cells both with or without E2 (data not shown). Parallel fil- 
ters with H4 junER cells were maintained in the absence 
of E2 for 5 d, allowing a strongly elevated TER to develop 
and  thereafter  treated  with  hormone  (Fig.  8 A, arrow, 
+E2).  Similar to c-FosER (Reichmann et al., 1992), acti- 
vation  of the  JunER  oncoprotein  disrupted  the  already 
formed functional tight junctions,  as indicated by the de- 
cline of TER after E2 addition (Fig. 8 A, filled symbols). 
In contrast, activation of JunER by addition of E2 and 
the constitutive expression of c-Jun in H4 c-jun cells (data 
not  shown)  completely inhibited  the  formation of func- 
tional tight junctions, as shown by the constantly low TER 
of the respective filter cultures  (Fig. 8 B, filled symbols). 
This  inhibition  was  completely  reversible.  When  H4 
junER cells were grown in the presence of hormone for 5 d 
and thereafter in the absence of hormone, (Fig. 8 B, arrow, 
-E2), the cells were still able to reach a TER value (open 
symbols) similar to that of uninduced  control ceils (com- 
pare to Fig. 8 A). 
Similar as in FosER cells treated with a  short pulse of 
E2 (Reichmann et al., 1992), the reversibility of the JunER 
induced loss of polarity could be confirmed by analyzing 
apical and basolateral polarization markers by immunoflu- 
orescence and confocal microscopy. All the proteins seen 
to  be  uniformly  distributed  to  the  whole  plasma  mem- 
brane in hormone-treated H4 junER cells became relocal- 
ized in a strictly apical or basolateral fashion, respectively, 
when the cells were switched to E2-free medium for one 
week (data not shown). Hence, even after 5 d of E2 treat- 
ment, H4 junER cells were still able to fully rebuild polar- 
ized monolayers and  to reform functional tight junctions 
upon hormone withdrawal. 
As a more stringent test for the ability of H4 junER cells 
to regain full epithelial polarity after hormone withdrawal, 
we examined if the cords of hormone-induced H4 junER 
cells formed in collagen gels after E2 treatment could rear- 
range  to  form  tubules  of  polarized  cells  when  E2  was 
washed  out  of the  collagen gels.  JunER-expressing  ceils 
were cultivated in gels in the absence of hormone to en- 
able  branching  and  lumen  formation.  Subsequently,  the 
tubular structures were disrupted by the addition of E2 for 
1-4 d and then kept without estrogen for another 7-9 d to 
check for repolarization and tubular reorganization. Within 
this  time  period  the  cells  were  able  to  reform  tubular 
The Journal of Cell Biology, Volume 132, 1996  1124 Figure  7. (A) JunER-induced disruption of tubular morphogenesis is inhibited by the lack of growth factors.  JunER-expressing cells 
were precultured in collagen gels for 12 d. TGFe~ and BPE (see Materials and Methods) as a source of other growth factors were with- 
drawn for 24 h (without GF). Subsequently,  E2 (+E2) or ethanol (-E2) were added for another 4 d in the absence of BPE/TGFa. Note 
the preservation of lumina even in the presence of E2. (B) aFGF mimics JunER-induced loss of epithelial polarity in parental H4 cells. 
H4 cells were cultured in collagen I gels for 11 d, photographed (0 h), and treated with heparin/aFGF (aFGF) or heparin alone (control) 
for 48 h. The branching  tubules obtained (top right panel, lumina  indicated by long arrows) collapsed in the aFGF-treated cultures (bot- 
tom right, long arrows). Lumina were retained in the cultures receiving only heparin (left panels; lumina indicated by short arrows). 
Fialka  et aL c-JunER-induced Reversible Loss of Polarity  1125 A 
200@ 
1500" 
C  1000" 
500" 
o{ 
B 
2000" 
A  1500" 
1000" 
t-  500" 
o!  t 
days 
2  4  6  8  10  1214  16 
days 
Figure 8. (A) Function  of preformed tight junctions  is destroyed 
by activated JunER. H4 junER cells were grown on filters with- 
out E2 to enable formation of functional tight junctions  as deter- 
mined by TER measurements (see Materials  and Methods).  On 
day 5 (arrow, +E2) E2 was added to one culture. Note progres- 
sive increase of TER in the absence of estradiol (open squares), 
while E2 addition  (filled squares) causes the TER to rapidly de- 
crease to levels obtained in cells grown continuous!y in E2 (com- 
pare to panel B, filled squares). (B) The inhibition  of tight junc- 
tion functionality  is reversible.  H4 junER cells cultured  in the 
presence of E2 for 5 d are unable to develop a high TER. After 
hormone withdrawal  on day 5 (empty squares, arrow, -E2) the 
cells gained a high TER (comparable to cells continuously grown 
in the absence of E2, see panel A, empty squares). This indicates 
that the cells are still able to reform functional  tight junctions. 
The other cell aliquot grown further in the presence of E2 failed 
to develop a high TER even after 14 d. 
structures of polarized monolayers (Fig. 9, top panels).  In 
agreement with the marker expression of repolarized cells 
on filters, cells within these tubules exhibited strictly baso- 
lateral 13-catenin  expression again (Fig. 9, bottom panels). 
If reverted H4 junER cells were allowed to form tubules in 
collagen gels without E2, these could be again induced to 
collapse by E2 (data not shown). We conclude from these 
data that the loss of epithelial polarity induced by JunER 
is completely reversible at any stage. 
Reversible Loss of Epithelial Polarity Caused by 
Activated JunER Is Associated with Reduced Stability 
of E-Cadherin/ fl-Catenin Complexes 
The  JunER-induced  loss  of epithelial  polarity  in  mam- 
mary epithelial cells is obviously associated with the redis- 
tribution and/or loss of various junctional proteins such as 
E-cadherin and ~3-catenin (see Figs. 4 and 6). Since cell ad- 
hesion  is  known  to  be  initiated  by  adherens  junctions 
(Balda et al., 1993; Fleming et al., 1993; Marrs et al., 1993; 
Watabe et al., 1994), we sought to further characterize the 
JunER effects on the adherens junctional complex. 
First, we investigated whether the expression of the E-cad- 
herin and [3-catenin proteins was downregulated upon pro- 
longed E2 treatment (4 d), as has been reported for E-cad- 
herin  after long-term c-FosER activation (Reichmann et 
al., 1992).  In Western blots using whole cell lysates we de- 
tected  no  or  only  minor  differences  in  E-cadherin  and 
13-catenin  levels (data not shown). Since the immunofluo- 
rescence  data  suggested that  the  latter  protein was par- 
tially  redistributed  to  the  cytoplasm  (see  Fig.  4),  unin- 
duced  and  induced  cells  were  grown  on  filters  and 
subjected to differential extraction using 2.5% NP-40 (Na- 
varro et al., 1993).  The detergent-insoluble (i) proteins be- 
ing  tightly  associated  with  the  cyto-  and/or  membrane- 
skeleton, and the soluble (s) fractions were separated by 
SDS-PAGE and analyzed for their content of E-cadherin 
and ~-catenin by immunoblots (Fig. 10 A). The blots ob- 
tained were then quantified by densitometry (see Materi- 
als and Methods).  The ratio of soluble  to insoluble  (s:i) 
E-cadherin  was  not  altered  in  any  of  the  cells  tested. 
About two-thirds of the protein were found in the insolu- 
ble  fraction  (s:i =  0.6)  in  JunER  or control  cells  either 
treated or not treated with E2. 
A  different behavior was seen for 13-catenin.  Fig.  10 A 
clearly shows that hormone activation of c-JunER caused 
a  strong decrease  in  insoluble  13-catenin.  These changes 
could be quantified by calculating the ratio soluble/insolu- 
ble  [3-catenin,  each normalized to  the  respective E-cad- 
herin levels. This normalized ratio of soluble to insoluble 
13-catenin  increased from 3.7 in untreated JunER cells to 
8.0  in cells treated with  estradiol.  No such  increase  was 
seen in control H4 ER(HBD) cells (Fig. 10 A), where the 
respective values were 3.3 in treated cells and 3.5 in cells 
not treated with hormone. 
To determine whether the enhanced solubility of 13-cate- 
nin was correlated with a change of complex formation be- 
tween E-cadherin and [3-catenin, we performed coimmu- 
noprecipitation-Western studies. H4 junER or control cells 
were grown on filters, treated or not treated with E2 for 
4  d, and extracted. Similar amounts of protein were sub- 
jected  to  immunoprecipitation  with  an  antibody  against 
E-cadherin, separated by SDS-PAGE blotted for immuno- 
detection  with  antibodies  to  E-cadherin  and  13-catenin, 
and quantified by densitometry as above. Again the amount 
of E-cadherin did not grossly change upon hormone addi- 
tion  (Fig.  10  B).  Strikingly,  however,  coimmunoprecipi- 
tated 13-catenin was diminished in induced H4 junER cells 
as  compared to untreated  and  control  cells  (Fig.  10 B). 
The ratio j3-catenin/E-cadherin in the immunoprecipitated 
complex (see Materials and Methods) decreased 2.9-fold 
in hormone-treated H4 junER cells, in comparison to un- 
treated cells.  In control cells,  this  ratio remained  essen- 
tially  constant  (H4  ER(HBD),  0.9-fold  difference;  Ep 
fosER cells, 1.1-fold difference). The MDCK ts v-src cells 
(used as a positive control for 13-catenin  phosphorylation, 
see Fig.  10  B  and  below)  could  not be analyzed in  this 
fashion, since the E-cadherin antibody did not cross-react 
to the dog protein under denaturing conditions. 
We conclude from these experiments that the regulatory 
protein 13-catenin is in part released from its complex with 
E-cadherin and is shifted from a detergent-insoluble to a 
more soluble state after JunER activation (see Discussion). 
JunER-induced Changes in fl-Catenin/E-Cadherin 
Interaction Do Not Involve Alterations in fl-Catenin 
Tyrosine Phosphorylation 
Recently, several groups have reported the  deregulation 
of E-cadherin-mediated  adhesiveness  via tyrosine  phos- 
phorylation of f3-catenin (Behrens et al., 1993; Hamaguchi 
et al., 1993; Sommers et al., 1994; Kinch et al., 1995). Since 
JunER induced similar changes, i.e., a loss of intercellular 
adhesion and a redistribution of these two proteins with- 
out changing their expression levels,  we determined  the 
state  of  13-catenin  tyrosine  phosphorylation  in  the  H4 
The Journal of Cell Biology,  Volume 132, 1996  1126 Figure 9. The JunER-induced loss of polarity in tubular structures is reversible. H4 junER cells were grown in collagen gels until tubular 
structures  had formed. Subsequently,  E2 was added for 2 d to induce luminal collapse and redistribution  of 13-catenin to the entire cell 
surfaces (+ E2). The structures were withdrawn from hormone and further cultivated in the absence of hormone under the appropriate 
conditions  for 7 d (+E2/-E2). The structures obtained were photographed (top panels). Ultrathin sections from the fixed structures 
were then prepared and subjected to on-section labeling (see legend to Fig. 6). Note the reformation of lumina (arrows) and regaining of 
basolateral expression of 13-catenin in the structures  after E2 withdrawal. 
junER  ceils.  As  a  positive  control,  ts  v-src-expressing 
MDCK  cells  (Behrens  et  al.,  1993)  were  analyzed after 
cultivation at the permissive (35.5°C)  and the nonpermis- 
sive (40.5°C) temperature. In none of the samples derived 
from JunER  cells before or after E2  treatment, or from 
the  various  control  cells  (including  Ep  fosER  cells)  any 
phosphorylation  of  13-catenin  on  tyrosine  could  be  de- 
tected (Fig. 10 B). The MDCK ts v-src control cells, on the 
other hand, showed the expected strong tyrosine phosphor- 
ylation of 13-catenin  at the permissive temperature, but not 
at 40.5°C (Fig. 10 B). This negative result was verified after 
extensive overexposure of the blot (data not shown). Thus, 
f3-catenin  tyrosine phosphorylation does not seem to be in- 
volved in the observed JunER-induced release of [3-catenin 
from E-cadherin and/or the cyto-/membrane-skeleton. 
Discussion 
In this paper, mouse mammary epithelial cells expressing a 
conditional  JunER  fusion  protein  have  been  employed. 
This system is expected to reflect the regulation of epithe- 
lial polarity in response to signal transduction induced by 
growth  factor  receptors.  The  data  obtained  show  that 
JunER reversibly modulates cellular polarity and tubular 
morphogenesis in mammary epithelial cells and implicate 
c-Jun as a nuclear effector of extracellular signaling in the 
regulation of mammary epithelial polarity. 
JunER, a Hormone-inducible Transcription Factor 
Acting on AP-I Target Genes 
Estrogen receptor fusion proteins have been successfully 
used for the analysis of many other transcription factors in 
different cell types (Briegel et al., 1993; Reichmann et al., 
1992). JunER-induced  transactivation (,--~50-fold) of a  re- 
porter gene via TRE(s) was fully dependent on E2 in fi- 
broblasts,  while  ER(HBD)  alone  failed  to  transactivate. 
Importantly, estradiol (E2) did not elicit any effects in pa- 
rental epithelial cells (H4) or cells expressing ER(HBD) 
under  the  given conditions,  although  these  cells  express 
the  endogenous  estrogen receptor (Fig.  1  C).  Therefore, 
clones expressing JunER could be selected and expanded 
in the absence of JunER activity, induced to fully polarize, 
and then exposed to the activated oncoprotein by addition 
of E2.  Similar to findings with the  conditional  transcrip- 
Fiatka et al. c-JunER-induced  Reversible  Loss of Polarity  1127 Figure 10. JunER destabilizes the E-cadherin/13-catenin  complex. 
(A) H4 junER and H4 ER(HBD) cells were cultivated on filters 
with (+) or without (-) E2 for 4 d. They were then differentially 
extracted with 2.5% NP-40. The detergent-soluble (s) and -insol- 
uble (i) fractions were analyzed by SDS-PAGE and immunoblot- 
ring.  Upon scanning by densitometry, the s:i ratios of 13-catenin 
normalized to E-cadherin  were calculated  (see numbers  at the 
bottom of lanes). About one third of 13-catenin is not extractable 
from H4 junER cells without E2, while almost all of the protein is 
found in the soluble fraction after the addition of hormone, thus 
raising the s:i ratio to 8.0. No increase in s:i is seen in the control 
H4 ER(HBD) cells (Note that less protein was loaded from the 
soluble fraction of H4 ER(HBD)  -E2).  (B) H4 ER(HBD) and 
H4 junER clones were treated as described in A. Extracts were 
then  immunoprecipitated  with  antiserum  against  E-cadherin. 
MDCK ts src cells grown at the permissive (35.5°C) or the restric- 
tive (40.5°C)  temperature and Ep losER cells ¥E2 were used as 
controls. Immunoprecipitates were analyzed on immunoblots us- 
ing the same c~-E-cadherin antibody (top  panel). After stripping, 
the blots were reprobed with an antibody to 13-catenin (middle 
panel) as well as with a phosphotyrosine antibody (bottom panel). 
Note that while E-cadherin expression does not change (less pro- 
tein was loaded in lane 4), a strongly reduced amount of 13-cate- 
nin is coimmunoprecipitated in H4 junER cells +E2. Densitome- 
try shows that the ratio 13-catenin/E-cadherin  is 2.9-fold reduced 
in  the  hormone-treated  cells  (compared  to  the  untreated  con- 
trols),  whereas  no  such  difference  is seen in  the  control  cells. 
Note also that the murine E-cadherin-specific antiserum is useful 
for immunoprecipitation in the canine cells but is nonreactive on 
the denatured proteins in immunoblots. 
tion factor GATA-2/ER  (Briegel et al., 1993), JunER was 
predominantly  nuclear when activated by E2 in epithelial 
cells, whereas most of the protein was cytoplasmic in con- 
trol cells not treated with hormone, supposedly due to in- 
teractions with heat shock proteins (Pratt and Welsh, 1994). 
As expected, activated JunER was able to regulate AP-1 
target gene expression in epithelial cells. The most promi- 
nent effect was seen on junB, which was repressed  almost 
sevenfold  after  only  2  h  of hormone  treatment.  JunB  is 
known to counteract c-Jun activity (Deng and Karin, 1993) 
and its expression is correlated with the differentiation  of 
various  cell  types  including  epithelial  cells  (Schlingen- 
siepen et al., 1993; Wilkinson et al., 1989). Thus, downreg- 
ulation of the negative effector JunB by c-Jun may prevent 
expression  of a  fully polarized  epithelial  phenotype.  The 
(much  weaker)  downregulation  of junD  mRNA,  a  third 
member of the Jun family (Ryder et al., 1989) is consistent 
with  the  expression  of JunD  in  quiescent  (Ryder  et  al., 
1989)  and  terminally  differentiated  cells  (Li et al.,  1992). 
Interestingly, JunD has recently been shown to antagonize 
fibroblast  growth  and  transformation  by  activated  Ras 
(Pfarr et al., 1994). 
Other  genes  affected  by JunER  were  the  AP-1  target 
genes fra-1,  the  protease  UPA  and  its  specific  inhibitor 
PAI-I. The expression of these genes was strongly affected 
by cell density and, consequently,  by the status of epithe- 
lial  polarity.  While  we  found  a  high  expression  level  in 
sparse cells, it was drastically  reduced  when  the  cells be- 
came dense enough to build up epithelial polarity. In line 
with  its ability to prevent epithelial  polarization,  E2-acti- 
vated  JunER  maintained  high  expression  of fra-1,  UPA, 
and PAI-1 mRNAs at cell densities where little or almost 
no  mRNA  was  detected  in  the  untreated  controls.  Sup- 
porting the significance of our data, upregulation  of UPA 
and PAI-1 has been correlated with a loss of epithelial cell 
adhesion  (Frixen  and  Nagamine,  1993)  and  a  degree  of 
malignancy in breast carcinomas (Reilly et al., 1992). 
Does JunER act in the same fashion as unmodified c-Jun? 
There  are several observations  that argue in favor of this 
idea.  First,  cloning  and  expansion  of  JunER-expressing 
clones in the presence of hormone gave rise to a nonpolar- 
ized  cell  type  similar  to  that  obtained  by  constitutively 
overexpressing bona fide c-Jun (unpublished  data). These 
cells  may have  undergone  cellular  progression  step(s)  in 
addition to overexpression of c-Jun. Alternatively, JunER 
may induce  epithelial-mesenchymal  transition  in  cells  at 
cloning density but not in a layer of already polarized cells. 
Furthermore,  JunER seems to respond to the same cel- 
lular regulatory mechanisms as c-Jun, c-Jun is posttransla- 
tionally  regulated  by phosphorylation  of several  Ser  and 
Thr residues, which either positively (Derijard et al., 1994; 
Minden  et  al.,  1994)  or  negatively  (Lin  et  al.,  1992;  Ni- 
kolakaki  et  al.,  1993)  affect  its  transactivation  potential. 
c-Jun function  is also regulated  by interaction  with  other 
nuclear factors such as nuclear hormone receptors (for re- 
view see Pfahl, 1993) and other negative regulators (Treier 
et  al.,  1994).  Interestingly,  hydrocortisone  at  higher  con- 
centrations  (250  ng/ml)  was  able  to  repress  the  JunER- 
induced  effects on tubular morphogenesis  (not shown).  In 
addition, omission of growth factors from the collagen gels 
inhibited  the JunER-induced  destruction  of polar epithe- 
lial  organization.  This  suggests  that,  similar to c-Jun,  up- 
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ceptors is required for JunER function. In line with this, 
aFGF could induce the same loss of tubular morphogene- 
sis  in normal H4 cells lacking an exogenous c-Jun(ER). 
Thus, we  assume  that endogenous c-Jun normally regu- 
lates epithelial polarity, if properly activated by extracellu- 
lar signals. Nevertheless, our data do not rule out that up- 
stream  signaling  by  serum  factors  may  also  alter  the 
function of the ER(HBD) in the fusion protein (Gabel- 
man and Emerman, 1992). 
Reversible Loss of Epithelial Polarity by Hormone 
Activation of JunER 
The results of this paper demonstrated that the activated 
JunER protein severely altered epithelial polarity. JunER 
caused a loosening of intercellular contacts and a redistri- 
bution of apical markers,  e.g., DPPIV  (Casanova et al., 
1991) and numerous basolateral markers to the entire cell 
surface. Redistribution of the tight junction protein ZO-1 
was correlated with a loss of functional tight junctions as 
determined by strongly reduced TER and by the clearly 
diminished numbers and abnormal structure of tight junc- 
tions detected by electron microscopy. Since the lumina of 
branched tubules formed in collagen gels are thought to be 
maintained by apical secretion, changes in the integrity of 
tight junctions induced by active JunER may cause api- 
cally secreted material to leak out into the gel and thus 
cause a destruction of already formed lumina. In addition, 
the JunER-induced  loss of polarity would also interfere 
with directed apical secretion per se (Streuli et al., 1991). 
Interestingly, changes in the production and apical secre- 
tion of milk proteins have already been reported to be in- 
duced by the oncogenes ras, mos, src, and neu (Dougall et 
al., 1994; Jehn et al., 1992), all of which are able to activate 
c-Jun and other AP-1 proteins. 
The formation of tight junctions as well as the polarized 
distribution of cell surface proteins is dependent on the in- 
tegrity  of adherens  junctions  (Marrs  et  al.,  1993,  1995; 
Watabe et al., 1994). Tight junction sealing is regulated by 
an E-cadherin-induced signal via protein kinase C (Balda 
et al.,  1993;  Lewis et al.,  1995). Thus, loss of functional 
tight junctions may be a consequence of impaired adher- 
ens junctions. This agrees with our finding that all proteins 
of the adherens junctions (E-cadherin, oL-, [3-catenin, and 
fodrin) were redistributed to the entire cell surface, both 
on filters and in collagen I gels. Furthermore, redistribu- 
tion of E-cadherin is known to be involved in the destabili- 
zation of cellular junctions in a number of human breast 
tumors (Oka et al., 1991). 
Activation of JunER causes the loss of high TER, polar- 
ized expression of apical and basolateral markers and the 
ability to form tubular structures in collagen gels. All of 
these parameters could be completely restored in the cells 
several days  after hormone withdrawal,  confirming that 
the JunER-induced effects were fully reversible. This indi- 
cates that activation of JunER does not repress epithelial 
marker  genes  and  induces  mesenchymal  ones,  as  does 
c-FosER  (Reichmann  et  al.,  1992),  but  rather  affects 
mechanisms involved in the maintenance of epithelial po- 
larity. Interestingly, loss of epithelial polarity after estro- 
gen induction was a fast process, apparently complete in 
24 h  or less, while restoration of polarity after estrogen 
withdrawal was slow, requiring 5-9 d depending on the pa- 
rameter assayed. The reasons for this slow kinetics of re- 
polarization are unknown at present. Since a  second E2- 
induced depolarization of the repolarized cells occurred as 
fast and complete as the initial one, epigenetic changes or 
alterations in c-JunER expression can be ruled out as ex- 
planations for the slow repolarization. 
Regulation of the E-Cadherin/fl-Catenin Complex 
Downregulation of E-cadherin is involved in carcinogene- 
sis and tumor cell invasiveness (Birchmeier and Behrens, 
1994; Frixen and Nagamine, 1993). Its adhesive function is 
dependent  on  the  association  with  several  cytoplasmic 
proteins named  catenins  (Gumbiner and  McCrea,  1993; 
Watabe et al., 1994). [3-Catenin is more directly interacting 
with E-cadherin than u-catenin (Aberle et al., 1994; Kawan- 
ishi  et  al.,  1995).  The  stability  of  13-catenin/E-cadherin 
complexes was strongly reduced after E2 induction, con- 
trary to the reduced cell adhesion observed in other cell 
types occurring without effects on catenin association (Beh- 
rens et al., 1993; Sommers et al., 1994). 
As  a possible regulatory event in catenin function, we 
have investigated tyrosine phosphorylation of [3-catenin. 
In other systems, tyrosine hyperphosphorylation has been 
correlated to inactivation of cadherin-dependent cell ad- 
hesion (Behrens et al., 1993; Hamaguchi et al., 1993; Som- 
mers et al., 1994) and was induced by growth factors (Ho- 
schuetzky et al., 1994). Nevertheless, we failed to detect 
elevated phosphotyrosine levels in [3-catenin, when epithe- 
lial  polarity  was  disrupted  by  c-JunER.  Very  recently, 
Kinch et al. (1995) demonstrated that tyrosine phosphory- 
lation of several proteins including ~-catenin was elevated 
in Ras-transformed human breast epithelial cells, causing 
the disruption of ~-catenin/E-cadherin complexes as well 
as enhanced solubility of both E-cadherin and ~3-catenin. 
Possibly, oncogenic activation of Ras  not  only activates 
c-Jun, but also other pathways that cause tyrosine phos- 
phorylation  of  ~-catenin,  increased  solubility  of E-cad- 
herin, and transformation. None of the latter effects were 
induced by activating JunER, indicating that c-Jun induces 
only a  subset  of the effects caused by oncogenic Ras in 
mammary epithelial cells. 
In line with our results, PDGF- or aFGF-induced changes 
in epithelial cell adhesion do not involve phosphorylation 
of [3-catenin (Boyer et al., 1992; Hoschuetzky et al., 1994). 
Acidic  FGF-induced  scattering,  epithelial-mesenchymal 
transition,  and  redistribution  of  E-cadherin  in  NBT-II 
bladder carcinoma cells did neither affect steady state lev- 
els nor the solubility of this protein. Together with the ob- 
servation  that  aFGF  was  able  to  mimic  the  JunER- 
induced effects in parental H4 cells, these results suggest 
that c-Jun may be one of the nuclear effectors of aFGF sig- 
naling in epithelial cells. 
Another level at which epithelial polarity may be regu- 
lated is the association of adherens junctions with the cy- 
toskeleton. Our finding that ~-catenin protein dissociates 
from E-cadherin and accumulates in the soluble fraction 
after JunER activation is in line with the observed correla- 
tion between enhanced solubility of [3-catenin and its dis- 
sociation from E-cadherin reported by Kinch et al. (1995). 
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duct of a tumor suppressor gene which is mutated in a fa- 
milial form of adenomatous polyposis coli and other intes- 
tinal tumors, strongly interacts with ~3-catenin. Both APC 
and E-cadherin bind to the same central core domain of 
13-catenin which contains the Arm-like repeats (for review 
see  Polakis,  1995).  Thus,  APC  possibly  competes  for 
13-catenin binding to E-cadherin (Hiilsken et al., 1994; Ru- 
binfeld et al., 1993). Very recently, nonmutated APC was 
proposed to be involved in degradation of the cytoplasmic 
form of 13-catenin (Munemitsu et al., 1995), also suggesting 
that the soluble form of this protein plays an important 
role in the deregulation of epithelial cells. 
A Role for c-Jun in Epithelial Cell Behavior 
and Breast Carcinogenesis? 
It is obvious that a certain plasticity of epithelial polarity is 
required in case of cell division, organ development, and 
remodeling,  as  well  as  wound  healing  (Birchmeier and 
Birchmeier, 1994; Nelson,  1992).  Likewise, this plasticity 
may be aberrantly regulated in carcinogenesis (Fish and 
Molitoris,  1994; Reichmann, 1994).  Our major reason to 
focus on c-Jun as a regulator of epithelial polarity was its 
likely function as  a  downstream effector integrating the 
signals from many different growth factor receptors that 
regulate epithelial cell behavior. 
Why are the JunER-induced changes distinct from those 
induced by c-FosER (Reichmann et al., 1992)? One possi- 
bility is that the set of genes regulated by JunER is clearly 
distinct  from  those  affected by  c-FosER.  For  instance, 
c-FosER, but not JunER, induces tissue-type plasminogen 
activator, collagenase I, and stromelysin I  (Reichmann et 
al., 1992; and data not shown). A possible reason for this is 
that c-Jun target genes important for transformation are 
regulated by heterodimers of c-Jun with transcription fac- 
tors  of the  ATF/CREB  family  (van  Dam  et  al.,  1993, 
1995), as has been shown in the case of PAl-1 regulation 
(Knudsen et al., 1994). 
In line with our findings, it has been recently reported 
that upregulation of c-Jun or JunB is neither sufficient to 
cause tumors nor to induce progression of a mild form of 
fibromatosis to a fully malignant tumor phenotype (Bossy- 
Wetzel  et  al.,  1992).  Thus,  c-Jun  is  probably unable  to 
cause tumors by itself, but rather induces a certain flexibil- 
ity in the polarized phenotype of mammary epithelial cells, 
perhaps by reversibly changing the expression of a limited 
number of AP-l-responsive genes. In line with this, c-jun 
mRNA accumulates in mouse mammary gland epithelial 
cells at regions of intensive organ remodeling during the 
first day(s) after delivery when the gland is preparing for 
lactation (Oft, M., and H. Beug, unpublished results). 
Although  unable  to cause tumors, JunER  may mimic 
early steps in breast cancer development, i.e., the loss of 
tight tissue organization. Our finding that aFGF induced 
the same changes in tubular morphogenesis as JunER cor- 
responds to the selective expression of a variant of FGFR-2 
at branching points of bronchioles in the developing mam- 
malian  lung  epithelium  (for  review  see  Mason,  1994). 
Moreover, a dominant negative FGFR was able to com- 
pletely block branching morphogenesis and epithelial dif- 
ferentiation of the mouse lung (Peters et al., 1994). Finally, 
members of the FGFR family have been found to be am- 
plified in a subset of human mammary tumors (Adnane et 
al., 1991). This suggests that aberrant FGF action via c-Jun 
can give rise to tumor development. Very recently, ele- 
vated levels of c-Jun expression leading to enhanced AP-1 
activity in mouse epidermal cell lines rendered these cells 
more sensitive to tumor promoting agents  (Dong et al., 
1994), supporting the hypothesis that c-Jun is involved in 
tumor initiation. 
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